These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1161533)

  • 1. [Effect of anti-inflammatory steroids on renal excretion of hydroxyproline in systemic lupus erythematosus].
    Cieślicka T
    Pol Arch Med Wewn; 1975 Aug; 54(2):101-7. PubMed ID: 1161533
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of antiphlogistic steroids on urinary hydroxyproline excretion in systemic lupus erythematosus.
    Cieślicka T
    Pol Med Sci Hist Bull (1973); 1976; 15(2):235-9. PubMed ID: 959050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normalizing effect of prednisone on excessive hydroxyprolinuria in active systemic lupus erythematosus.
    Cieślicka T
    Mater Med Pol; 1976; 8(4):448-52. PubMed ID: 1027962
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hydroxyproline excretion in urine in chronic connective tissue disease].
    Emmrich R
    Z Gesamte Inn Med; 1970 Dec; 25(23):1062-5. PubMed ID: 4397769
    [No Abstract]   [Full Text] [Related]  

  • 5. [Polycardiographis assessment of the cardiovascular system in patients with systemic lupus erythematosus on long-term treatment with anti-inflammatory steroids].
    Szmydt W; Wierzchowiecki M; Rybicka K
    Pol Tyg Lek; 1978 Jul; 33(28):1097-9. PubMed ID: 704406
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical significance of urinary hydroxyproline excretion].
    Kreysel HW; Köhler N
    Med Welt; 1973 Oct; 24(43):1654-8. PubMed ID: 4764061
    [No Abstract]   [Full Text] [Related]  

  • 7. [Urinary hydroxyproline excretion in generalized bone diseases].
    Czitober H; Raab W
    Wien Z Inn Med; 1967; 48(10):401-8. PubMed ID: 5620579
    [No Abstract]   [Full Text] [Related]  

  • 8. [The behavior of hydroxyproline in urine in rheumatic children and their families].
    Vedovini F; Pieri J; Gorelli L
    Riv Clin Pediatr; 1966 Dec; 78(6):744-57. PubMed ID: 5999595
    [No Abstract]   [Full Text] [Related]  

  • 9. [Our expeiences in treatment of patients with systemic lupus erythematosus with steroids].
    Wierzchowiecki M; Witoszyński S
    Pol Arch Med Wewn; 1968; 40(4):503-10. PubMed ID: 5669082
    [No Abstract]   [Full Text] [Related]  

  • 10. [Proteinuria, enzymuria and histuria in systemic lupus erythematosus and related diseases].
    Cebecauer L; Rovenský J; Hajzok O
    Fysiatr Revmatol Vestn; 1976 Feb; 54(1):24-31. PubMed ID: 944676
    [No Abstract]   [Full Text] [Related]  

  • 11. [Analysis of the macromolecular component of the urine in lupus-nephritis].
    Cebecauer L; Zitnan D; Rovenskỳ J
    Vnitr Lek; 1971 May; 17(5):417-23. PubMed ID: 4269694
    [No Abstract]   [Full Text] [Related]  

  • 12. Hydroxychloroquine has no significant effect on lipids and apolipoproteins in Chinese systemic lupus erythematosus patients with mild or inactive disease.
    Tam LS; Li EK; Lam CW; Tomlinson B
    Lupus; 2000; 9(6):413-6. PubMed ID: 10981644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of steroid therapy on the course of systemic lupus erythematosus].
    Wierzchowiecki M; Witoszyński S
    Clin Ter; 1968 Apr; 45(1):3-13. PubMed ID: 5734895
    [No Abstract]   [Full Text] [Related]  

  • 14. Decreased bone mineral density in female patients with systemic lupus erythematosus after long-term administration of Tripterygium Wilfordii Hook. F.
    Huang L; Feng S; Wang H
    Chin Med J (Engl); 2000 Feb; 113(2):159-61. PubMed ID: 11775543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prednisone effect on urinary excretion of hydroxyproline in patients with muscular dystrophy.
    Kibrick AC; Power HL; Sevendal E; Milhorat AT
    J Clin Endocrinol Metab; 1968 Aug; 28(8):1113-9. PubMed ID: 5676175
    [No Abstract]   [Full Text] [Related]  

  • 16. Predictors of cognitive dysfunction in patients with systemic lupus erythematosus.
    McLaurin EY; Holliday SL; Williams P; Brey RL
    Neurology; 2005 Jan; 64(2):297-303. PubMed ID: 15668428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of pituitary-adrenal reserve in patients with systemic lupus erythematosus treated with steroids].
    Witoszyński S; Wierzchowiecki M; Adamiak S
    Pol Arch Med Wewn; 1967; 39(4):483-8. PubMed ID: 4295765
    [No Abstract]   [Full Text] [Related]  

  • 18. Alterations in circulating fatty acid composition in patients with systemic lupus erythematosus: a pilot study.
    Aghdassi E; Ma DW; Morrison S; Hillyer LM; Clarke S; Gladman DD; Urowitz MB; Fortin PR
    JPEN J Parenter Enteral Nutr; 2011 Mar; 35(2):198-208. PubMed ID: 21378249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Observation on effect of qi-supplementing blood-activating and stasis-removing principle in treating patients with systemic lupus erythematosus of blood-stasis type].
    Wu JL; Bao XH; Zhou ZL
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 Nov; 23(11):860-1. PubMed ID: 14666773
    [No Abstract]   [Full Text] [Related]  

  • 20. Core decompression for osteonecrosis of the femoral head in systemic lupus erythematosus.
    Mont MA; Fairbank AC; Petri M; Hungerford DS
    Clin Orthop Relat Res; 1997 Jan; (334):91-7. PubMed ID: 9005900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.